Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis

Clinical Immunology

Volumn 91, Issue 1, 1999, Pages 61-67

  Abramson, Leslie S ^a   Albertini, Richard J ^b   Pachman, Lauren M ^c   Finette, Barry A ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

HPRT; Juvenile dermatomyositis; T cells

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; ARTICLE; BLOOD; CHILD; CLONOGENIC ASSAY; DERMATOMYOSITIS; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MUTATION; ONSET AGE; PRESCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; AGE OF ONSET; ASPARTATE AMINOTRANSFERASES; CHILD; CHILD, PRESCHOOL; COLONY-FORMING UNITS ASSAY; CREATINE KINASE; DERMATOMYOSITIS; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE FREQUENCY; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTE ACTIVATION; MALE; MUTATION; T-LYMPHOCYTES;

EID: 0033112673     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4675     Document Type: Article

References (20)

1. + NK cells in muscle biopsies (MBx) from DQA1*0501 positive untreated children with juvenile dermatomyositis (JDM) very early in their disease course. In "Pediatric Rheumatology into the Next Century," 1998. [abstract; in press]
2. Albani, S. et al., Identification of cross-reactive epitopes on human skeletal myosin and streptococcal M5 protein in patients with JDM. Arthritis Rheum. 40(9), S140, 1997. [abstract]
3. Albertini, R. J. et al., In vivo somatic mutations in humans: Measurement and analysis. Annu. Rev. Genet. 24, 305-326, 1990.
4. Allegretta, M. et al., T-cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247, 718-721, 1990.
5. Gmelig-Meyling, F., Dawisha, S., and Steinberg, A. D., Assessment of in vivo frequency of mutated T-cells in patients with systemic lupus erythematosus. J. Exp. Med. 175, 297-300, 1992.
6. Holyst, M. M. et al., Increased frequency of mutations in the hprt gene of T-cells isolated from patients with anti-U1-70kD autoantibody positive connective tissue disease. Int. Arch. Allergy Immunol. 105(3), 234-237, 1994.
7. Finette, B. A. et al., Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat. Res. 308, 223-231, 1994.
8. Robinson, D. et al., An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four databases. Mutat. Res. 313, 227-247, 1994.
9. Sfikakis, P. P. et al., Increased frequency of in vivo hprt genemutated T cells in the peripheral blood of patients with systemic sclerosis. Ann. Rheum. Dis. 53, 122-127, 1994.
10. Sriram, S., Longitudinal study of frequency of hprt mutant T cells in patients with Multiple Sclerosis. Neurology 44, 311-315, 1994.
11. Van den Berg, L. H. et al., Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barre' syndrome and chronic inflammatory demyelinating polyneuropathy: Further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases. J. Neuroimmunol. 58, 37-42, 1995.
12. Ansari, A. A. et al., Frequency of hypoxanthine guanine phosphoribosyltransferase (HPRT) T cells in the peripheral blood of cardiac transplant recipients. Circulation 92(4), 862-874, 1995.
13. Allegretta, M. et al., Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. J. Clin. Invest. 94, 105-109, 1994.
14. Trotter, J. L. et al., HPRT mutant T cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides. J. Neuroimmunol. 75(1-2), 95-103, 1997.
15. Theocharis, S. et al., Characterization of in vivo mutated T cell clones from patients with Systemic Lupus Erythematosus. Clin. Immunol. Immunopathol. 74, 135-142, 1995.
16. Dawisha, S. M., Gmelig-Meyling, F., and Steinberg, A. D., Assessment of clinical parameters associated with increased frequency of mutant T-cells in patients with systemic lupus erythematosus. Arthritis Rheum. 37(2), 270-277, 1994.
17. Bohan, A., and Peter, J. B., Polymyositis and dermatomyositis (Part 1). N. Engl. J. Med. 292, 344-347, 1975.
18. O'Neill, J. P. et al., Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 2, 87-92, 1987.
19. Eisenstein, D. M., O'Gorman, M. R. G., and Pachman, L. M., Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with Juvenile Dermatomyositis. J. Rheumatol. 24, 1803-1832, 1997.
20. O'Neill, J. P. et al., The effect of T-lymphocyte "clonality" on the calculated hprt mutation frequency occurring in vivo in humans. Mutat. Res. 313, 215-225, 1994.